Acomplia, known in the United States as Zimulti, is a weight loss drug that was approved for use in Europe in June of 2006, but has yet to be approved in the United States. Acomplia is the first Cannabinoid-1 Receptor Blocker, a new line of obesity drugs that work by blocking the Canabinoid-1 ... Click to read the article details